Tafolecimab Injection is the first independently developed original fully humanized PCSK9 monoclonal antibody in China, characterized by dual-effect and potent lipid-lowering efficacy, long-acting and convenient administration, as well as favorable safety and tolerability.
Authentic
Guarantee
Fast Delivery
Privacy Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



